The Manufacturers Life Insurance Company reduced its stake in RTI Surgical Inc (NASDAQ:RTIX) by 5.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 45,723 shares of the medical equipment provider’s stock after selling 2,723 shares during the period. The Manufacturers Life Insurance Company owned about 0.08% of RTI Surgical worth $268,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Cigna Investments Inc. New acquired a new stake in RTI Surgical during the 2nd quarter worth approximately $105,000. Citigroup Inc. boosted its position in RTI Surgical by 2,850.1% during the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after buying an additional 20,435 shares during the period. Thompson Davis & CO. Inc. boosted its position in RTI Surgical by 138.8% during the 2nd quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after buying an additional 14,577 shares during the period. Bank of America Corp DE boosted its position in RTI Surgical by 6.4% during the 1st quarter. Bank of America Corp DE now owns 39,786 shares of the medical equipment provider’s stock worth $159,000 after buying an additional 2,389 shares during the period. Finally, Brandywine Global Investment Management LLC acquired a new stake in RTI Surgical during the 2nd quarter worth approximately $183,000. Institutional investors own 69.92% of the company’s stock.
RTI Surgical Inc (NASDAQ:RTIX) opened at $4.50 on Wednesday. The company has a current ratio of 3.34, a quick ratio of 1.21 and a debt-to-equity ratio of 0.25. RTI Surgical Inc has a fifty-two week low of $3.01 and a fifty-two week high of $6.00. The stock has a market cap of $282.87, a P/E ratio of 116.25, a price-to-earnings-growth ratio of 6.20 and a beta of 1.76.
Several research firms recently commented on RTIX. BidaskClub downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a research report on Tuesday, August 8th. Zacks Investment Research upgraded shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th.
ILLEGAL ACTIVITY WARNING: “RTI Surgical Inc (RTIX) Shares Sold by The Manufacturers Life Insurance Company” was posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this article on another domain, it was illegally copied and republished in violation of U.S. & international copyright laws. The legal version of this article can be accessed at https://www.chaffeybreeze.com/2017/12/06/rti-surgical-inc-rtix-shares-sold-by-the-manufacturers-life-insurance-company.html.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Want to see what other hedge funds are holding RTIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for RTI Surgical Inc (NASDAQ:RTIX).
Receive News & Ratings for RTI Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.